Compared conventional and new stimulation methods for intractable neuropathic pai
- Conditions
- europathic pain
- Registration Number
- JPRN-jRCT1042220094
- Lead Sponsor
- Saito Ryuta
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 92
Patients with intractable neuropathic pain resistance to medication treatments using more than two drugs
-18 years of age or older
-Pain scale of VAS (Visual analog scale) is more than 4 point
-Patients who have obtained written consent from the patient
-Patients receiving anti-cancer therapy
-Patients with a history of drug abuse
-Patients with histories of spine or spinal cord surgery at the site through which the spinal cord stimulation electrode passes or will be placed
-Patients for whom local and general anesthesia cannot be performed
-Patients with high risk of surgery, such as patients with unstable angina pectoris and with end-stage liver disease presenting with hepatic encephalopathy
-Patients with diabetes mellitus who are not well controlled (HbA1c 9% or more)
-Patients with serious complications (liver disease, kidney disease, heart disease, lung disease, blood disease, brain disease, etc.)
-Pregnant or potentially pregnant patients
-Patients who are considered as inappropriate by a head of research or research assignations
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method